Cigna's Evernorth is rolling out a new pharmacy benefit management program that caps members' monthly cost for key GLP-1 ...

The Cigna Group (NYSE:CI)’s Evernorth division has announced a new deal with Novo Nordisk and Eli Lilly that will limit ...

Cigna’s (NYSE:CI) health services arm, Evernorth, has launched a pharmacy benefit program that caps out-of-pocket costs at ...

Cigna's Evernorth business caps GLP-1 drug copays at $200 or less, aiming to boost affordability for patients and cut costs ...

The new weight-loss option will cut what the plan sponsors pay as well as what the patients pay, Cigna’s PBM Evernorth says.

Getting access to popular weight loss drugs will be simpler and cheaper for some.Health insurer Cigna (CI) announced a new ...

Cigna subsidiary Evernorth Health Services will automate prior authorizations for GLP-1 weight-loss drugs under a new program ...

Investing.com — 周四，Truist Securities维持对Hims & Hers Health Inc. (NYSE: HIMS )的持有评级，目标价为45.00美元。Truist的分析师就Evernorth最近关于减肥药物保险覆盖的公告进行了评论。Evernorth是信诺公司 (Cigna Corporation, ...

Cigna’s pharmacy benefits unit Evernorth said the deal will bring prices down for employers and their workers.

Investing.com -- Cigna’s Evernorth has introduced a new pharmacy benefit that caps out-of-pocket costs for GLP-1 weight loss ...

Investing.com — 周四，花旗分析师Daniel Grosslight重申了对Hims and Hers Health Inc. (NYSE: HIMS )股票的卖出评级，目标价为30.00美元。根据 InvestingPro ...

Cigna is reducing monthly out-of-pocket costs to $200 for patients using weight-loss drugs Wegovy and Zepbound. These ...